Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India.

Burza S, Nabi E, Mahajan R, Mitra G, Lima MA.

Clin Infect Dis. 2013 Nov;57(9):1363-4. doi: 10.1093/cid/cit508. Epub 2013 Aug 13. No abstract available.

PMID:
23943824
[PubMed - indexed for MEDLINE]
2.

Miltefosine presents new hope for leishmaniasis patients.

Paterson R.

Lancet Infect Dis. 2002 Aug;2(8):452. No abstract available.

PMID:
12150830
[PubMed - indexed for MEDLINE]
3.

Miltefosine in the treatment of a case of visceral leishmaniasis with renal dysfunction.

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Verma N, Lal CS, Das P, Bhattacharya SK.

Ann Trop Med Parasitol. 2007 Oct;101(7):649-51. No abstract available.

PMID:
17877883
[PubMed - indexed for MEDLINE]
4.

Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India.

Thakur CP, Sinha PK, Singh RK, Hassan SM, Narain S.

Trans R Soc Trop Med Hyg. 2000 Nov-Dec;94(6):696-7. No abstract available.

PMID:
11198660
[PubMed - indexed for MEDLINE]
5.

Treatment of leishmaniasis with miltefosine: 2008 status.

Berman JJ.

Expert Opin Drug Metab Toxicol. 2008 Sep;4(9):1209-16. doi: 10.1517/17425255.4.9.1209. Review.

PMID:
18721114
[PubMed - indexed for MEDLINE]
6.

Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.

Murray HW.

Future Microbiol. 2010 Sep;5(9):1301-3. doi: 10.2217/fmb.10.92. No abstract available.

PMID:
20860475
[PubMed - indexed for MEDLINE]
Free Article
7.

Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients.

Marques N, Sá R, Coelho F, Oliveira J, Saraiva Da Cunha J, Meliço-Silvestre A.

Scand J Infect Dis. 2008;40(6-7):523-6. doi: 10.1080/00365540701787800.

PMID:
18584541
[PubMed - indexed for MEDLINE]
8.

Oral miltefosine for Indian visceral leishmaniasis.

Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J.

N Engl J Med. 2002 Nov 28;347(22):1739-46.

PMID:
12456849
[PubMed - indexed for MEDLINE]
Free Article
9.

What steps can be taken to counter the increasing failure of miltefosine to treat visceral leishmaniasis?

Sundar S, Singh A.

Expert Rev Anti Infect Ther. 2013 Feb;11(2):117-9. doi: 10.1586/eri.12.170. No abstract available.

PMID:
23409817
[PubMed - indexed for MEDLINE]
10.

Availability of miltefosine for the treatment of kala-azar in India.

Sundar S, Murray HW.

Bull World Health Organ. 2005 May;83(5):394-5. Epub 2005 Jun 24. No abstract available.

PMID:
15976883
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Efficacy of oral miltefosine in visceral leishmaniasis in rural West Bengal, India.

Patra P, Guha SK, Maji AK, Saha P, Ganguly S, Chakraborty A, Kundu PK, Sarker S, Ray K.

Indian J Pharmacol. 2012 Jul-Aug;44(4):500-3. doi: 10.4103/0253-7613.99326.

PMID:
23087513
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.

Bhattacharya SK, Jha TK, Sundar S, Thakur CP, Engel J, Sindermann H, Junge K, Karbwang J, Bryceson AD, Berman JD.

Clin Infect Dis. 2004 Jan 15;38(2):217-21. Epub 2003 Dec 18.

PMID:
14699453
[PubMed - indexed for MEDLINE]
Free Article
13.

A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy.

Kumar N, Sinha PK, Pandey K, Verma N, Lal CS, Ranjan A, Verma RB, Das P.

Int J Clin Pharm. 2011 Oct;33(5):726-9. doi: 10.1007/s11096-011-9544-8. Epub 2011 Jul 22.

PMID:
21833710
[PubMed - indexed for MEDLINE]
14.

Miltefosine for visceral leishmaniasis.

Eibl H.

N Engl J Med. 2000 Mar 23;342(12):894-5. No abstract available.

PMID:
10733376
[PubMed - indexed for MEDLINE]
Free Article
15.

A case of miltefosine responsive pleomorphic post kala-azar dermal leishmaniasis.

Pal D, Naskar A, Ghosh MK.

Braz J Infect Dis. 2013 Sep-Oct;17(5):610-2. doi: 10.1016/j.bjid.2012.12.011. Epub 2013 Sep 5. No abstract available.

PMID:
24012431
[PubMed - indexed for MEDLINE]
Free Article
16.

Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.

Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB, Das P.

Am J Trop Med Hyg. 2009 Mar;80(3):336-8.

PMID:
19270277
[PubMed - indexed for MEDLINE]
Free Article
17.

Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.

Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H, Ganguly NK.

J Infect Dis. 2007 Aug 15;196(4):591-8. Epub 2007 Jun 29.

PMID:
17624846
[PubMed - indexed for MEDLINE]
Free Article
18.

Use of miltefosine in the treatment of visceral leishmaniasis in children at a tertiary care hospital of Karachi.

Humayun KN, Saleem T, Khalid U, Jehan F, Soofi S.

J Pak Med Assoc. 2010 Jun;60(6):489-91.

PMID:
20527651
[PubMed - indexed for MEDLINE]
19.

[Miltefosine: a new remedy for leishmaniasis].

Dorlo TP, Eggelte TA, Beijnen JH, de Vries PJ.

Ned Tijdschr Geneeskd. 2006 Dec 9;150(49):2697-701. Review. Dutch.

PMID:
17194005
[PubMed - indexed for MEDLINE]
20.

Miltefosine for Indian visceral leishmaniasis.

Roca B.

N Engl J Med. 2003 Feb 27;348(9):857-8; author reply 857-8. No abstract available.

PMID:
12608397
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk